Cargando…
Aptamer Internalization via Endocytosis Inducing S-Phase Arrest and Priming Maver-1 Lymphoma Cells for Cytarabine Chemotherapy
The goal of precision therapy is to efficiently treat cancer without side effects. Aptamers are a class of small ligands composed of single-stranded oligonucleotides that bind to their targets with high affinity and specificity. In this study, we identified an ssDNA aptamer specifically targeting Ma...
Autores principales: | Li, Huan, Yang, Shuanghui, Yu, Ge, Shen, Liangfang, Fan, Jia, Xu, Ling, Zhang, Hedong, Zhao, Nianxi, Zeng, Zihua, Hu, Tony, Wen, Jianguo, Zu, Youli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399587/ https://www.ncbi.nlm.nih.gov/pubmed/28435459 http://dx.doi.org/10.7150/thno.17069 |
Ejemplares similares
-
Biostable ssDNA Aptamers Specific for Hodgkin Lymphoma
por: Parekh, Parag, et al.
Publicado: (2013) -
ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 Cells
por: Yu, Ge, et al.
Publicado: (2016) -
Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy
por: Zeng, Zihua, et al.
Publicado: (2020) -
Interleukin-2 Functions in Anaplastic Large Cell Lymphoma Cells through Augmentation of Extracellular Signal-Regulated Kinases 1/2 Activation
por: Ito, Masanori, et al.
Publicado: (2011) -
Aptamer technology: a new approach to treat lymphoma?
por: Zu, Youli
Publicado: (2020)